{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:40:08Z","timestamp":1756284008414,"version":"3.44.0"},"reference-count":22,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,7,12]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:p>Herpes simplex virus (HSV) encephalitis affects 2\u20134 people per million\/year. Immunocompomised patients can have atypical presentations of HSV encephalitis, including a lack of cerebrospinal fluid (CSF) pleocytosis. We present the case of a patient who was receiving ustekinumab therapy for psoriasis which inhibits interleukin (IL)-12 and IL-23 signalling pathways. The initial presentation was suggestive of encephalitis, but he was discharged prior to the reporting of HSV positivity due to the lack of CSF pleocytosis. On representation, he had worsening symptoms and imaging showed midline shift, indicating cerebral oedema despite the immunosupressant effects of ustekinumab. He required intensive care unit support and treatment with high dose aciclovir and dexamethasone; after a month of treatment he made a good recovery. This case is the first to report a link between ustekinumab and HSV encephalitis, and also emphasises that imunocompromised patients can lack CSF pleocytosis and develop significant cerebral oedema which responds to immune suppression.<\/jats:p>","DOI":"10.1136\/bcr-2019-229468","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T07:17:44Z","timestamp":1565767064000},"page":"e229468","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Herpes simplex virus encephalitis in a patient receiving ustekinumab associated with extensive cerebral oedema and brainshift successfully treated by immunosuppression with dexamethasone"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"isrctn11774734","registry":"10.18810\/isrctn"}],"author":[{"given":"Harriet Kay","family":"Van Den Tooren","sequence":"first","affiliation":[{"name":"Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viraj","family":"Bharambe","sequence":"additional","affiliation":[{"name":"Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Silver","sequence":"additional","affiliation":[{"name":"Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict D","family":"Michael","sequence":"additional","affiliation":[{"name":"Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK"},{"name":"Department of Clinical Infection Microbiology and Immunology, Institute of Infection and Global Health, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"2025082701025652000_12.8.e229468.1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-016-0433-7"},{"key":"2025082701025652000_12.8.e229468.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2011.11.014"},{"key":"2025082701025652000_12.8.e229468.3","doi-asserted-by":"crossref","unstructured":"Schadler ED , Ortel B , Mehlis SL . Biologics for the primary care physician: Review and treatment of psoriasis. Dis Mon 2019;65.doi:10.1016\/j.disamonth.2018.06.001","DOI":"10.1016\/j.disamonth.2018.06.001"},{"key":"2025082701025652000_12.8.e229468.4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3851\/IMP2683","article-title":"A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy?","volume":"19","author":"Ramos-Estebanez","year":"2014","journal-title":"Antivir Ther"},{"key":"2025082701025652000_12.8.e229468.5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3851\/IMP3110","article-title":"Herpes simplex type 2 encephalitis and methotrexate medication: a fortuitous or causative association in a patient with spondyloarthritis?","volume":"22","author":"Lupo","year":"2017","journal-title":"Antivir Ther"},{"key":"2025082701025652000_12.8.e229468.6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1631\/jzus.B1600460","article-title":"Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection","volume":"18","author":"Zhang","year":"2017","journal-title":"J Zhejiang Univ Sci B"},{"key":"2025082701025652000_12.8.e229468.7","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3895"},{"key":"2025082701025652000_12.8.e229468.8","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000175"},{"key":"2025082701025652000_12.8.e229468.9","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-011-0609-2"},{"key":"2025082701025652000_12.8.e229468.10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s15010-015-0822-6","article-title":"Chronic herpes simplex type-1 encephalitis with intractable epilepsy in an immunosuppressed patient","volume":"44","author":"Laohathai","year":"2016","journal-title":"Infection"},{"key":"2025082701025652000_12.8.e229468.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001659"},{"key":"2025082701025652000_12.8.e229468.12","doi-asserted-by":"publisher","DOI":"10.1086\/605498"},{"key":"2025082701025652000_12.8.e229468.13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/omcr\/omu001","article-title":"Recurrence of herpes simplex encephalitis associated with temozolomide chemoradiation for malignant glioma: a case report and review of the literature","volume":"2014","author":"Christman","year":"2014","journal-title":"Oxf Med Case Reports"},{"key":"2025082701025652000_12.8.e229468.14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1159\/000484553","article-title":"Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment","volume":"10","author":"van Montfort","year":"2017","journal-title":"Case Rep Oncol"},{"key":"2025082701025652000_12.8.e229468.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077805","article-title":"Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"2025082701025652000_12.8.e229468.16","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182374a34"},{"key":"2025082701025652000_12.8.e229468.17","doi-asserted-by":"publisher","DOI":"10.1177\/1756285612456234"},{"key":"2025082701025652000_12.8.e229468.18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13054-015-1046-y","article-title":"Long-term outcome of severe herpes simplex encephalitis: a population-based observational study","volume":"19","author":"Jouan","year":"2015","journal-title":"Crit Care"},{"key":"2025082701025652000_12.8.e229468.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.03.010"},{"key":"2025082701025652000_12.8.e229468.20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.049676"},{"key":"2025082701025652000_12.8.e229468.21","doi-asserted-by":"publisher","DOI":"10.1080\/13550280390173373"},{"key":"2025082701025652000_12.8.e229468.22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mcn.2018.04.002","article-title":"Brain microvascular endothelial-astrocyte cell responses following Japanese encephalitis virus infection in an in vitro human blood-brain barrier model","volume":"89","author":"Patabendige","year":"2018","journal-title":"Mol Cell Neurosci"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-229468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:03:04Z","timestamp":1756281784000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-229468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,13]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/bcr-2019-229468"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-229468","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}